Shopping Cart
- Remove All
- Your shopping cart is currently empty
CAY10704 is a potent inhibitor of hepatitis C virus (HCV) infection (EC50 = 17 nM) that displays low cytotoxicity of virally-infected human hepatoma Huh7.5.1 cells (CC50 = 21.3 μM). It displays good pharmacokinetics in mice when delivered intraperitoneally, with preferential liver distribution without significant hepatotoxicity. CAY10704 is selective for HCV over dengue virus (EC50 = 4.62 μM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | 116 € | 35 days | |
5 mg | 513 € | 35 days | |
10 mg | 902 € | 35 days |
Description | CAY10704 is a potent inhibitor of hepatitis C virus (HCV) infection (EC50 = 17 nM) that displays low cytotoxicity of virally-infected human hepatoma Huh7.5.1 cells (CC50 = 21.3 μM). It displays good pharmacokinetics in mice when delivered intraperitoneally, with preferential liver distribution without significant hepatotoxicity. CAY10704 is selective for HCV over dengue virus (EC50 = 4.62 μM). |
Molecular Weight | 335.27 |
Formula | C18H20Cl2N2 |
Cas No. | 101784-44-5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO: 20 mg/mL DMF: 20 mg/mL Ethanol: 16 mg/mL DMF:PBS(pH7.2) (1:2): 0.3 mg/mL |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.